SkinBioTherapeutics (SBTX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

15.75p
   
  • Change Today:
    -0.75p
  • 52 Week High: 29.00
  • 52 Week Low: 14.50
  • Currency: UK Pounds
  • Shares Issued: 173.14m
  • Volume: 242,511
  • Market Cap: £27.27m

SBTX Overview

SkinBioTherapeutics is a life science company focused on skin health. The Company’s proprietary platform technology, SkinBiotix®, is based upon discoveries made by CSO Dr. Catherine O’Neill and Professor Andrew McBain at The University of Manchester.

1 Day Chart (31-05-2023)

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -3633.1% n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 364.8 n/a
Pr/Book 9.9  
Latest F'cast
Revenue n/a n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

SBTX Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-18 n/a (0.94) (0.71)p n/a n/a n/a n/a 0.0%
30-Jun-19 n/a (1.36) (0.94)p n/a n/a n/a n/a 0.0%
30-Jun-20 n/a (1.62) (1.17)p n/a n/a n/a n/a 0.0%
30-Jun-21 n/a (1.50) (0.01)p n/a n/a n/a n/a 0.0%
30-Jun-22 0.07 (2.73) (1.61)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

SBTX Company Announcements

SkinBiotix and AxisBiotix Update 10-May-2023 07:00 RNS
Director/PDMR Shareholding 14-Apr-2023 07:00 RNS
Replacement Half-year Report 28-Mar-2023 13:45 RNS

SBTX ShareCast News

SkinBioTherapeutics pleased with progress on two... 10-May-2023 ShareCast
SkinBioTherapeutics reports progress with psoria... 17-Feb-2022 ShareCast
SkinBioTherapeutics commercially launches psoria... 29-Oct-2021 ShareCast

Latest SBTX Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

SBTX Market Data

Currency UK Pounds
Share Price 15.75p
Change Today -0.75p
% Change -4.55 %
52 Week High 29.00
52 Week Low 14.50
Volume 242,511
Shares Issued 173.14m
Market Cap £27.27m

SBTX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
63.46% below the market average63.46% below the market average63.46% below the market average63.46% below the market average63.46% below the market average
70% below the sector average70% below the sector average70% below the sector average70% below the sector average70% below the sector average
Price Trend
77.5% below the market average77.5% below the market average77.5% below the market average77.5% below the market average77.5% below the market average
44.26% below the sector average44.26% below the sector average44.26% below the sector average44.26% below the sector average44.26% below the sector average
Income Not Available
Growth Not Available

SBTX Dividends

No dividends found

Trades for 31-May-2023

Time Volume / Share Price
16:16 50,000 @ 15.60p
15:50 7,500 @ 16.01p
15:25 27,778 @ 16.00p
14:43 15,287 @ 16.03p
10:51 6,106 @ 16.18p

SBTX Key Personnel

CEO Stuart Ashman
CFO Manprit Singh Randhawa

Top of Page